BioCryst Pharmaceuticals
BCRX
BCRX
272 hedge funds and large institutions have $1.31B invested in BioCryst Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 110 increasing their positions, 68 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.45% more ownership
Funds ownership: 80.95% → 83.4% (+2.5%)
4% more capital invested
Capital invested by funds: $1.26B → $1.31B (+$52.9M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
272
Holding in Top 10
3
Calls
$9.58M
Puts
$4.8M
Top Buyers
| 1 | +$22.7M | |
| 2 | +$16.2M | |
| 3 | +$9.55M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$7.28M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$5.88M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$22.2M | |
| 3 | -$18.4M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$4.03M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$3.39M |
